Циклодекстрины на фармацевтическом рынке Европы – тенденции отрасли и прогноз до 2030 года

Анализ и размер европейского фармацевтического рынка циклодекстринов

В последнее время ожидается, что циклодекстрины на фармацевтическом рынке будут значительно расти в прогнозируемый период 2023-2030 гг. Циклодекстрины широко используются в производстве косметики и средств личной гигиены, таких как маски для лица, кремы и лосьоны, среди прочего, и, как прогнозируется, увеличат расширение рынка в ближайшие годы. В то же время, растущая популярность пищевых добавок для повышения иммунитета во всем мире, вероятно, увеличит расширение рынка в прогнозируемый период.

Data Bridge Market Research анализирует темпы роста циклодекстринов на фармацевтическом рынке в прогнозируемый период 2023–2030 гг. Ожидаемый среднегодовой темп роста циклодекстринов на фармацевтическом рынке, как правило, составляет около 4,2% в указанный прогнозируемый период. Рынок оценивался в 32,8 млн долларов США в 2022 году и вырастет до 45,5 млн долларов США к 2030 году. Помимо таких рыночных данных, как рыночная стоимость, темпы роста, сегменты рынка, географический охват, участники рынка и рыночный сценарий, рыночный отчет, подготовленный командой Data Bridge Market Research, также включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Циклодекстрины в Европе. Масштаб и сегментация фармацевтического рынка

Market Definition

Cyclodextrins are the kind of complex cyclic sugar which is made up of a macrocyclic ring of glucose subunits that is linked together by alpha-1,4 glycosidic linkages. Cyclodextrin is formed when a starch is decomposed enzymatically into simple molecules. Cyclodextrin is widely used in the pharmaceutical and chemical industries in the form of solvent component in medication delivery. Cyclodextrin is widely used to increase drug water solubility, stability, and bioavailability by encapsulating hydrophobic medicinal molecules in biological systems.   

Europe Cyclodextrins in Pharma Market Dynamics

Drivers

• Increasing Consumption of Dietary Supplements

The increasing consumption of dietary supplements is projected to increase the market's growth. Excipients such as cyclodextrin are used in pharmaceutical and nutraceutical formulations. Also because of COVID-19 pandemic, physicians have prescribed a wide variety of antiviral therapeutics to patients to help them fight the virus early on. The increasing use of these medications has increased the cyclodextrin consumption, boosting market growth throughout the forecast period 2023-2030.

• Increasing investment for healthcare infrastructure

Another factor that is boosting the growth of the cyclodextrins in pharma market is the increasing healthcare expenditure that helps in improving its infrastructure. Additionally, numeorus government organizations aim to develop the healthcare infrastructure by growing their funding to influence cyclodextrins dynamics in the pharma market. Moreover, rising initiatives by private and public organizations to increase awareness will increase the demand for cyclodextrins in the pharma market. Furthermore, the huge drift of consumer behavior towards health and the rising use of cyclodextrins in renal diseases will also increase the cyclodextrins in pharma market growth.

Opportunities

• Huge Application in Drug Solubility And Dissolution

Cyclodextrins have a wide application in drug solubility and dissolution which are anticipated to dominate the market because of the presence of cyclodextrins for many administrations, such as oral, gastrointestinal, top-of-the-line drugs to increase drug efficacy. Thus, this boosts the market growth.   

• Rising Adoption of Direct Tender Segment

The direct tender channel is majorly increasing the market growth since the drugs are used for the cyclodextrins in pharma that can be obtained through direct tender on reasonable price and the patients receive treatment for prolonged period of time. Therefore, this factor enhances the market growth.

Restraints/Challenges

• High Cost of Treatment

Numerous treatment methods require surgery and high-end medications that demand huge cost. The lower economic groups cannot retrieve these treatment processes. Therefore, this factor impedes the market growth since the treatment options are not feasible for all the economic groups.

• Lack of Reimbursement Policies

There is a lack of reimbursement for cyclodextrins in pharma, which are expected to restrict the market growth. Both public and private payers do not compensate majority of the treatment services. The high cost of such services vary much and there cannot be any standardization. Therefore, this factor hampers the market growth.

This cyclodextrins in pharma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cyclodextrins in pharma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Europe Cyclodextrins in Pharma Market Scope

The cyclodextrins in pharma market is segmented on the basis of type, structure, nature, form, application, therapeutic areas and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Β Cyclodextrin
• 2-Hydroxypropyl-Β-Cyclodextrin
• Α Cyclodextrin
• γ-Cyclodextrin
• Randomly Methylated Β-Cyclodextrin
• Sulfobutylether Β-Cyclodextrin
• 2-Hydroxypropyl-Γ-Cyclodextrin

Structure

• Cyclodextrin Conjugates
• Mucoadhesive Drug Carriers
• Cyclodextrin Associates
• Amphiphilic Cyclodextrins
• Others

Nature

• Hydrophilic
• Hydrophobic

Form

• Solid
• Liquid

Application

• Drug Solubility and Dissolution
• Drug Bioavailability
• Drug Safety
• Drug Stability
• Others

Therapeutics Area

• Pain Management
• Cardiovascular Diseases
• Behavioral Disorder
• Cancer Therapy
• Rheumatoid Arth​​​​​​​ritis
• Epilepsy
• Niemann Pick Disease Type C (NPC)
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Others

Cyclodextrins in Pharma Market Regional Analysis/Insights

The cyclodextrins in pharma market is analyzed and market size insights and trends are provided by type, structure, nature, form, application, therapeutic areas and distribution channel as referenced above.

The major countries covered in the cyclodextrins in pharma market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany leads the Europe cyclodextrins in pharma market because of the large number of companies, R & D capabilities and the increasing adoption of cyclodextrin in the pharma industry.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Europe Cyclodextrins in Pharma Market Share Analysis

The cyclodextrins in pharma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cyclodextrins in pharma market

Key players operating in the cyclodextrins in pharma market include:

• Cambrex Corporation (U.S.)
• Cayman Chemical (U.S.)
• Wellona Pharma (India)
• Wacker Chemie AG (Germany)
• Tocopharm Co. Limited (China)
• Roquette Frères (France)
• Midas Pharma GmbH (Germany)
• Ligand Pharmaceuticals Incorporated (США)
• Cyclo Therapeutics, Inc. (США)
• Zibo Qianhui biotechnology co., ltd (Китай)
• Xi'an Deli Biochemical Industry Co., Ltd (Китай)
• Merck KGaA (Германия)
• Otto Chemie Pvt. Ltd. (Индия)
• VIO CHEMICALS (Швейцария)
• Эшленд (США)
• TCI Chemicals (Индия) Pvt. Ltd. (Япония)

SKU-55854